## 3 Results
In the group of animals that received the Eleutherococcus extracts, an increase in the activity of SOD of the heart was observed, in comparison with the rats that were given the enzyme gamma-butyrobetaine hydroxylase inhibitor. The effects of two phytopreparations differed in their influence on the activity of SOD, GPO and AST of the heart. \begin{table}
\begin{tabular}{c c c c c c c c c c} \hline \hline \multirow{2}{*}{**Group**} & \multirow{2}{*}{**Group**} & \multicolumn{2}{c}{**SOD**} & \multicolumn{2}{c}{**GPO**} & \multicolumn{2}{c}{**AST**} & \multicolumn{2}{c}{**ALT**} \\ \cline{3-10}  & & **Heart** & **Liver** & **Heart** & **Liver** & **Heart** & **Liver** & **Heart** & **Liver** & **Heart** & **Liver** \\ \hline \multirow{3}{*}{Control group} & \multirow{3}{*}{1} & 71.43\% & 90.62\% & 73.61\% & 84.62\% & 53.85\% & 380.87\% & 37.21\% & 6.45\% \\  & & (61.33\% \div\) & (84.10\% \div\) & (63.76\% \div\) & (76.55\% \div\) & (42.70\% \div\) & (307.73\% \div\) & (26.40\% \div\) & (0.96\% \div\) \\  & & 91.23\%)* & 103.40\%) & 92.93\%)* & 100.43\%) & 75.69\%)* & 524.21\%)* & 58.39\%)* & 17.22\%)* \\ \hline \multirow{3}{*}{0.9\% NaCl} & \multirow{3}{*}{2} & 74.70\% & 61.74\% & 74.36\% & 87.43\% & 77.14\% & 252.07\% & 19.89\% & 30.85\% \\  & & (64.98\% \div\) & (50.88\% \div\) & (64.60\% \div\) & (80.02\% \div\) & (67.75\% \div\) & (208.29\% \div\) & (10.96\% \div\) & (20.52\% \div\) \\  & & 93.75\%)* & 83.05\%)* & 93.50\%)* & 101.96\%) & 95.55\%)* & 337.88\%)* & 37.38\%)* & 51.09\%)* \\ \hline \multirow{3}{*}{Inhibitor of the enzyme gamma-butyrobetaine hydroxylase} & \multirow{3}{*}{3} & 96.00\% & 92.83\% & 85.60\% & 112.90\% & 105.16\% & 112.42\% & 108.27\% & 112.74\% \\  & & (91.62\% \div\) & (87.07\% \div\) & (77.75\% \div\) & (104.37\% \div\) & (99.95\% \div\) & (104.07\% \div\) & (101.58\% \div\) & (104.26\% \div\) \\  & & 104.59\%)* & 104.14\%)2 & 100.99\%) & 129.63\%) & 129.63\%) & 12.80\%) & 121.38\%) & 129.35\%) \\  & & & & & & & & \\  & & & & & & & & & \\  & & & & & & & & & \\  & & & & & & & & & \\ \hline \multirow{3}{*}{Eleutherococcus extract} & \multirow{3}{*}{5} & 134.78\% & 48.65\% & 81.05\% & 78.05\% & 94.65\% & 25.08\% & 9.69\% & 91.99\% \\  & & (119.47\% \div\) & (37.47\% \div\) & (72.28\% \div\) & (68.79\% \div\) & (89.62\% \div\) & (15.39\% \div\) & (3.07\% \div\) & (85.92\% \div\) \\  & & 164.79\%) & 70.55\%) & 98.22\%)* & 96.19\%)* & 34.15\%) & 40.68\%)* & 22.65\%)* & 103.89\%)* \\  & & & & & & & & & \\  & & & & & & & & & \\  & & & & & & & & & \\ \hline \multirow{3}{*}{Notes. Here and below \(p<0.05\); *—differences from the initial level of enzyme activity; 1–4—differences from the level of enzyme activity in animals of the corresponding group; results present as odds ratios with \(p<0.05\) interval.} \\ \cline{1-1}  & & & & & & & & & \\ \end{tabular}
\end{table} 
Table 2: Changes in enzyme activity from baseline under acute stress conditions. In chronic stress conditions (Table 4), one can speak of a violation of the processes of antioxidant cells protection against the background of increasing processes of cytolysis. In this case, the inhibitor of the enzyme gamma-butyrobetaine hydroxylase, as in the case of acute and subacute stress, has a protective effect. Under chronic stress conditions, the effects of the Eleutherococcus extract are more similar to those of the enzyme gamma-butyrobetaine hydroxylase inhibitor than the Liguscium wallichi extract. Apparently, Liguscium wallichi extract is more cytoprotective against hepatocytes than cardiomyocytes, as evidenced by an increase in the AST/ALT ratio of the heart against the background of the decrease in this ratio for the liver.